What does Ocumetics Technology Corp. do?

Ocumetics Technology Corp. (OTC.V) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is OTC.V's market cap?

Ocumetics Technology Corp. (OTC.V) has a market capitalization of approximately $26.2 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does OTC.V pay a dividend?

No — Ocumetics Technology Corp. (OTC.V) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Ocumetics Technology Corp. (OTC.V) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

OTC.V

Ocumetics Technology Corp.

TSXV·Medical, Instruments & Supplies · Healthcare

C$0.45C$0.02+3.49%

Market capC$26.21M·Market closed·Aug 27 7:28 PM UTC

Price Chart

C$0.45+C$0.02 (+3.49%)today

−23.28%CAGR −5.20%

Select date range

FromTo

Sep 10, 2021Sep 10, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

OTC.V does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 28

Last Report DateAug 28

Reported vs Estimate−C$0.03

Earnings Surprise—

FinancialsFinancials Tab

RevenueC$0.00

Net Income−C$8.29M

Net Margin—

Operating Cash Flow−C$2.99M

Capital ExpendituresC$118.23K

Free Cash Flow−C$3.06M

Return on Equity—

Return on Invested Capital−166.8%

Net DebtC$5.26M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for OTC.V and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how OTC.V's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OTC.V and 80,000+ other tickers.

About Ocumetics Technology Corp.

Ocumetics Technology Corp. is an innovation-driven enterprise specializing in the development and production of diverse optical lenses. One of its key innovations is the Bionic Lens, an expandable intraocular lens crafted to be implanted within the eye's natural lens compartment, offering a solution that eliminates the need for external vision correction. The company maintains its corporate headquarters in Calgary, Canada.

CEO: Dean E. Burns
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: TSXV
Employees: 5
Website: ocumetics.com

Peers

Peers Tab

TLT.V

Theralase Technologies Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About OTC.V

What does Ocumetics Technology Corp. do?: Ocumetics Technology Corp. (OTC.V) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is OTC.V's market cap?: Ocumetics Technology Corp. (OTC.V) has a market capitalization of approximately $26.2 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does OTC.V pay a dividend?: No — Ocumetics Technology Corp. (OTC.V) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is OTC.V profitable?: Ocumetics Technology Corp. (OTC.V) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.